News Alzheimer's drug Leqembi launched in first EU markets Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen's much-delayed treatment for Alzheimer's.
News Healthcare bills to pay? Let hi.health pick up the tab Just over a year ago, hi.health launched an app that takes the legwork out of submitting reimbursement claims to private health insurers.
Partner Content Partner Content Anthill extends its presence in DACH region Anthill, a digital communications agency focused on the life science industry, is expanding its services for local clients based in Germany, Austria and Switzerland.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.